Consequences of Direct-to-Consumer Advertising
This article focuses on a new study that suggests drug price increases are engineered to cover the costs of Direct-to-Consumer Advertising (DTCA). Drug price trend data from AARP, AHRQ, and prescription drug consumer price index (CPI) are presented.
Topic headings include:
- AARP Rx Watchdog Report Data
- Flaws in the AARP Report
- Engineered Drug Price Increase
- DTC Ad Spend Chart
- Industry Says No Direct Link to DTC
- Plavix and Medicaid
- Smoking Gun Charts
- Pharmacos Spend More on DTCA When There is No Competition
- Plausible or Dubious?